## HRL: Hormel Foods Corporation - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 3.0% below STRENGTH zone (4.0-10.0%); PEG 3.39 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($22.42)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 1, Bearish: 0)

**1. Jim Cramer Says “It is Not Crazy to Believe That Hormel’s Close to a Turnaround”**
- Source: Insider Monkey | 20251129T125300 | Neutral | Relevance: 99%
- Jim Cramer commented on Hormel Foods Corporation (NYSE:HRL), suggesting a potential upcoming turnaround despite current high commodity costs impacting margins. He notes the stock is relatively cheap, trading at less than 16 times next year's numbers, and offers a 5.1% dividend yield with good sales momentum. However, he advises caution before the upcoming earnings report due to recent CFO departure and hopes for a post-earnings dip to buy in weakness after management presents a credible cost structure improvement plan.

**2. Franklin Resources Inc. Raises Stock Position in Hormel Foods Corporation $HRL**
- Source: MarketBeat | 20251201T090309 | Neutral | Relevance: 99%
- Franklin Resources Inc. substantially increased its holdings in Hormel Foods Corporation by 67.4% in the second quarter, now owning 296,782 shares valued at approximately $8.98 million. Despite this increased institutional interest, Hormel Foods recently missed EPS expectations and has a consensus "Hold" rating from analysts with an average target price of $28.86. The company also announced a quarterly dividend increase to $0.2925 per share, resulting in a 5.0% annualized yield.

**3. Jim Cramer Says “It is Not Crazy to Believe That Hormel’s Close to a Turnaround”**
- Source: Yahoo Finance | 20251129T175300 | Somewhat-Bullish | Relevance: 99%
- Jim Cramer believes Hormel Foods Corporation (NYSE: HRL) is close to a turnaround, citing good sales momentum despite challenges from GLP-1 weight loss drugs and high commodity costs impacting margins. He notes that the stock is "fairly cheap," trading at less than 16 times next year's earnings. Cramer suggests that while the packaged food sector faces pressure, Hormel's focus on protein and strong demand for its products position it for recovery.

**4. Jim Cramer Says "It is Not Crazy to Believe That Hormel's Close to a Turnaround"**
- Source: Finviz | 20251129T125300 | Neutral | Relevance: 99%
- Jim Cramer suggests that Hormel Foods Corporation (HRL) could be nearing a turnaround despite challenges from GLP-1 drugs and high commodity costs affecting its margins. He notes strong sales momentum and an attractive dividend yield but advises caution before the upcoming earnings report, especially given a recent CFO departure. Cramer hopes for a disappointing quarter that could lead to a credible plan for cost structure improvement, making it a viable buying opportunity.

**5. How Hormel Foods' (HRL) 60th Consecutive Dividend Hike Reinforces Its Investment Narrative**
- Source: Simply Wall Street | 20251129T033955 | Somewhat-Bullish | Relevance: 98%
- Hormel Foods (HRL) announced its 60th consecutive annual dividend increase of 1%, reinforcing its investment narrative amidst operational challenges. The company's focus on operational efficiency and recent restructuring efforts aim to offset commodity inflation and achieve revenue and earnings targets by 2028. This long-term dividend growth record and future projections are key for investors evaluating Hormel's financial stability and potential upside.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-09 | Barclays | $30 | $31 | -3% |
| 2025-12-05 | Piper Sandler | $26 | $25 | +4% |
| 2025-12-05 | JP Morgan | $28 | $27 | +4% |
| 2025-12-05 | B of A Securiti | $26 | $25 | +4% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-09 | Barclays | main | Overweight |
| 2025-12-05 | Piper Sandler | main | Neutral |
| 2025-12-05 | JP Morgan | main | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 4 ($0.26M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 24.9% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 10 / 0 |

**Top Holders:**
- Vanguard Group Inc: 6.8% (+2.0%)
- State Street Corpora: 5.1% (+1.0%)
- Blackrock Inc.: 4.6% (+2.2%)
- Invesco Ltd.: 2.1% (+66.5%)
- Geode Capital Manage: 1.5% (+1.7%)

### Key Risks

1. Valuation risk: PEG 3.4x with declining EPS estimates leaves no margin for error.
2. Long-term trend broken: trading 16.0% below SMA200.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +4%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 3.39 signals overvaluation risk, limited margin of safety. Forward P/E 14.9x stretched relative to 7% growth. Balance sheet: strong liquidity (2.5x), low leverage (D/E 0.18). Institutional flow bullish (10 buying vs 0 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $13.1B |
| Beta | 0.33 |
| 52W Range | $21.03 - $33.80 |
| Short Interest | 5.8% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 3.39 |
| Forward P/E | 14.9 |
| Current P/E | 15.9 |
| YoY Growth | 6.9% |
| EPS Direction | FALLING |

### Technicals

MRS_20 stable at 3.0% (minimal 5-day change). Below STRENGTH zone by 1.0pp (needs >4.0% for momentum thesis). MRS_5 at 0.5% confirms short-term momentum alignment. AM_20 at 4.1% shows strong absolute momentum above own 20MA. Below SMA200 (0.84x), long-term trend not supportive. RSI neutral at 58.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 2.97% (CS: 79) | Neutral |
| RSI_14 | 58.1 | Neutral |
| MACD Histogram | 0.21 | Bullish |
| vs SMA20 | 1.041x | Above |
| vs SMA50 | 1.001x | Above |
| vs SMA200 | 0.840x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $23.30
- **Stop Loss:** $22.42 (3.8% risk)
- **Target:** $24.18 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 1363
- **Position Value:** $31,757.90
- **Portfolio %:** 31.76%
- **Risk Dollars:** $1,200.00
- **Risk Per Trade:** 1.20%
- **Modifiers:** L1 100% | L2 120% | Combined 1.20x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | TREND (Zone A) | 1.20x |

### Earnings

**Next:** 2026-02-26 (Est: $0.32)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.30 | $0.32 | +6.0% |
| 2025Q3 | $0.41 | $0.35 | -14.5% |
| 2025Q2 | $0.34 | $0.35 | +3.3% |
| 2025Q1 | $0.37 | $0.35 | -6.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*